Auto-generated: April 14 2021 11:05 AM GMT

155
Stars
Star This?

Source: Hum Vaccin Immunother  |  Posted 3 years ago

Update on oral immunotherapy for egg allergy; Graham F, Tardio N, Paradis L, Des Roches A, B├ęgin P; Human Vaccines & Immunotherapeutics (Jul 2017)

Oral immunotherapy (OIT) is an emerging treatment for IgE-mediated egg allergy. In the past decade, a multitude of studies have assessed the potential for egg OIT to induce clinical desensitization. The following review will evaluate the efficacy and safety of this therapy as determined by randomized controlled, non-randomized controlled and uncontrolled trials. Recent studies using reduced allergenic egg products and anti-IgE assisted therapy to improve egg OIT safety will also be discussed. Recent advances in the mechanisms underlying food OIT suggest that certain immune parameters may be helpful in monitoring response to therapy, including egg OIT. Although, egg OIT is consistently shown to be effective with regards to clinical desensitization, fewer studies have looked at persistent tolerance or sustained unresponsiveness. Limited results of long-term follow-up trials suggest that this therapy may have disease-modifying effects. In general, the comparison of studies is complicated by major differences in study designs, OIT protocols and endpoints.

155
Stars
Star This?  Yes / No
 
1
Sign InSign In
inst val